Earnings call transcript: Universal sees strong FY2025, Q4 dips

Universal Corporation (UVV) reported a 75% increase in full-year revenue to $2.95 billion, driven by strategic investments and expansion; however, Q4 revenue declined to $702.3 million from $770.9 million year-over-year, leading to a 1.47% drop in after-hours trading, closing at $58.51. Despite the quarterly dip, the company reduced net debt by $180 million and completed an expansion in Pennsylvania, while InvestingPro data indicates a 35.23% return over the past year and a 5.52% dividend yield, suggesting underlying financial strength despite investor concerns over short-term performance.

Analysis

Universal Corporation (UVV) reported a robust fiscal year 2025, characterized by a significant 75% increase in full-year revenue to $2.95 billion and a 5% rise in full-year operating income to $232.8 million, underscoring successful strategic investments and expansion efforts, notably the completion of a major ingredients platform expansion in Lancaster, Pennsylvania. However, the fourth quarter presented a contrasting picture, with revenue declining to $702.3 million from $770.9 million year-over-year, and Q4 operating income falling to $42.8 million from $68.2 million, primarily attributed to the accelerated timing of tobacco shipments earlier in the fiscal year. Consequently, Q4 adjusted EPS was $0.80, down from $1.79 in the prior year, and net income for FY2025 fell to $95 million from $119.6 million, impacted by higher interest expenses and one-off charges like a pension settlement. Despite the quarterly softness and a subsequent 1.47% dip in aftermarket stock price to $58.51, the company demonstrated improved financial stability by reducing net debt by $180 million. The stock has yielded a 35.23% return over the past year, trading near its 52-week high, supported by a strong 5.52% dividend yield, an attractive P/E ratio of 11.7, and a 55-year history of dividend increases. For FY2026, Universal anticipates stronger demand in its tobacco segment as the market potentially shifts from undersupply to a more balanced state with increased global production, alongside a strategic focus on organic growth and margin improvement in its burgeoning ingredients segment. Management highlighted the completion of the Mozambique investigation with no material financial impact and plans capital expenditures of $45-$55 million, prioritizing deleveraging and strategic investments over immediate share repurchases. Key risks include potential tariff impacts, evolving nicotine pouch market dynamics, and inventory management amid fluctuating demand.

Key Decisions for Investors

• Investors should weigh Universal's strong full-year performance, consistent dividend growth, and debt reduction against the Q4 revenue and income decline, considering the stock is trading near its 52-week high and slightly above its InvestingPro Fair Value.
• Closely monitor the ingredients segment's ability to drive organic growth and achieve targeted margin improvements following the Lancaster expansion, as this is pivotal for future diversification and profitability.
• Assess the impact of the anticipated shift in the tobacco market towards a more balanced supply in FY2026, particularly how it affects pricing, volumes, and Universal's ability to manage customer inventory strategies and maintain tobacco segment profitability.
• Consider the company's capital allocation strategy, which currently prioritizes debt reduction and strategic investments over share buybacks, and stay alert to external risks such as tariffs and the evolving dynamics of the nicotine products market.